Discover how entrepreneurial and business thinking drives translational medicine and is essential for developing new therapies and products in order to save patients' lives.
After the presentation, you will understand:
- How entrepreneurial and business thinking is driving translational medicine and saving lives
- The importance of understanding clinical and medical details for sustainable business models
- The role of cooperative business models in achieving innovation and competitive advantage
Dr. Ingo Schroeter
Ingo, a former partner at the Boston Consulting Group, worked for over 15 years in Technology Practice, including MedTech. As Head of Strategy & Partnering at Philips, he played a key role in transforming Philips into a digital health tech company. He was part of the World Economic Forum's steering committee for Precision Medicine and built Philips Corporate Venturing. Since 2018, Ingo has been advising various life science, MedTech, and digital health startups, as well as companies in biotech, pharma, and digital health sectors. In 2019, he founded econican GmbH to foster new forms of cooperation in medical research through digital platform solutions.
This webinar will be hosted by SPARK-BIH
Online via Zoom | Please register here!
Registration to the webinar is required in advance. Please register no later than 4th February 2025. Please note that you will receive the Zoom link and access code the evening before the lecture and that access to last minute registrations, cannot be guaranteed.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland, SPARK Tel Aviv, SPARK Denmark, SPARK Zürich and SPARK at the Faculty of Medicine, Masaryk University. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.
